The group’s principle activity is to develop novel therapeutics and other products based on distinctive technologies. The group’s products are used in molecular biology, drug discovery and medical treatment. The group’s markets include medical device, diagnostic, drug delivery, tools and other life sciences companies. The group operates from North America and Europe.
